- Home
- QNST vs ORIC Comparison
QNST vs ORIC Comparison
Compare QNST & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNST
- ORIC
- Stock Information
- Founded
- QNST 1999
- ORIC 2014
- Country
- QNST United States
- ORIC United States
- Employees
- QNST N/A
- ORIC N/A
- Industry
- QNST Business Services
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- QNST Consumer Discretionary
- ORIC Health Care
- Exchange
- QNST Nasdaq
- ORIC Nasdaq
- Market Cap
- QNST 923.2M
- ORIC 1.1B
- IPO Year
- QNST 2010
- ORIC 2020
- Fundamental
- Price
- QNST $15.39
- ORIC $14.41
- Analyst Decision
- QNST Buy
- ORIC Strong Buy
- Analyst Count
- QNST 6
- ORIC 8
- Target Price
- QNST $27.33
- ORIC $16.57
- AVG Volume (30 Days)
- QNST 459.4K
- ORIC 1.5M
- Earning Date
- QNST 11-03-2025
- ORIC 11-11-2025
- Dividend Yield
- QNST N/A
- ORIC N/A
- EPS Growth
- QNST N/A
- ORIC N/A
- EPS
- QNST 0.08
- ORIC N/A
- Revenue
- QNST $1,093,711,000.00
- ORIC N/A
- Revenue This Year
- QNST $10.72
- ORIC N/A
- Revenue Next Year
- QNST $9.66
- ORIC N/A
- P/E Ratio
- QNST $193.75
- ORIC N/A
- Revenue Growth
- QNST 78.27
- ORIC N/A
- 52 Week Low
- QNST $14.27
- ORIC $3.90
- 52 Week High
- QNST $26.27
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- QNST 41.65
- ORIC 76.34
- Support Level
- QNST $15.17
- ORIC $11.13
- Resistance Level
- QNST $16.39
- ORIC $12.13
- Average True Range (ATR)
- QNST 0.58
- ORIC 0.77
- MACD
- QNST -0.14
- ORIC 0.24
- Stochastic Oscillator
- QNST 11.34
- ORIC 94.64
About QNST QuinStreet Inc.
QuinStreet Inc focuses on marketplaces and technologies for the financial services and home services industries. It delivers measurable and cost-effective marketing results to its clients, in the form of qualified inquiries such as clicks, leads, calls, applications, or customers. It generates revenue by delivering measurable online marketing results to the clients. Its products and services are Customer Acquisition, QuinStreet Rating Platform (QRP), and CloudControlMedia.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.